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Abstract: There have been increasing reports on the presence of Histoplasma capsulatum in some 
European countries. The study investigated the presence of Histoplasma in bat guanos, 
speleologists with records of visiting Histoplasma-endemic regions and patients with 
histoplasmosis. A commercial ALPHA Histoplasma Antigen enzyme immunoassay was 
tested as an alternative methodology to detect Histoplasma in environment and compared 
with polymerase chain reaction (PCR) assays. The presence of Histoplasma antigen in bat 
guanos was not confirmed by PCR. Among 14 healthy speleologists, two were indicated as 
having the Histoplasma antigen in urine, but expressed negative PCR-specific results for the 
Histoplasma antigen. Five unequivocal cases of imported acute pulmonary histoplasmosis in 
Slovenia between years 2005 and 2016 were confirmed in patients returning from North and 
South America after visiting hazardous localities e.g., caves with guano, and places with dust. 
Currently there is no evidence of autochthonous histoplasmosis in Slovenia, or that bat guano 
is a source of H. capsulatum. Involvement of histoplasmosis in travellers’ and cavers’ morbidity 
might be underestimated in non-endemic areas. It is crucial to ensure the use of appropriate 
protective equipment in Histoplasma hazardous localities, to spread information about this 
hazardous microbe to vulnerable populations and to monitor the health of the environment. 
A differential diagnosis for a febrile respiratory disease outbreak in patients returning from 
endemic regions should trigger routine consideration of possible histoplasmosis.
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INTRODUCTION
Histoplasmosis is an endemic mycosis caused by a 
dimorphic fungus with two distinct varieties that are 
pathogenic to humans, i.e., Histoplasma capsulatum 
var. capsulatum and Histoplasma capsulatum var. 
duboisii. The latter is known to be restricted to sub-
Saharan Africa, whereas the former is distributed 
worldwide. H. capsulatum occurs in the soils of 
endemic areas, especially those contaminated by 
bird and bat droppings. Environmental disruption 
of Histoplasma habitats that introduces spores into 
the air is commonly a key factor associated with 
histoplasmosis outbreaks. Cave visitation, mining, 
building-site work, and agricultural activities are all 
associated with an increased risk of histoplasmosis 
(Kasuga et al., 2003; Kauffman; 2007 Antinori, 2014).
After inhalation of airborne Histoplasma micro-
conidia, a majority of those exposed develop 
subclinical, self-limited, and commonly unrecognized 
disease symptoms. These are more likely to manifest 
after high-inoculum exposures, possibly with 
more intrinsically virulent strains, especially in 
immunocompromised patients and in very young 
and very old individuals. Those immunocompetent 
patients that do develop symptoms, most commonly 
present with acute pulmonary histoplasmosis, a »flu-
like« illness, whereas severe or disseminated forms of 
histoplasmosis usually occur in immunocompromised 
individuals (Wheat et al., 2016).
Most reported cases of histoplasmosis in Europe are 
in immigrants or travellers returning from endemic 
areas, including the Americas, Africa, Southeast Asia, 
and East Australia (Bahr et al., 2015). According to an 
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epidemiological survey of the European Confederation 
of Medical Mycology Working Group, some parts of 
Italy might be considered endemic for H. capsulatum 
(Ashbee et al., 2008). H. capsulatum var. capsulatum 
has been isolated from soil and animals in the Emilia 
Romagna region of Italy, and histoplasmin reactivity 
surveys in Lombardy, Tuscany and Apulia showed 
a low positivity in the general population (Sotgiu et 
al., 1966; Confalonieri et al., 1994; Mavropoulou et 
al., 2010; Reginato et al., 2014). In particular, the 
identification of some autochthonous cases in the 
Po Valley suggests the possible endemic presence 
of histoplasmosis in Italy (Manfredi et al., 1994; 
Farina et al., 2000, 2005; Calza et al., 2003; Ashbee 
et al., 2008). A few apparently autochthonous cases 
have been reported in other European countries, 
especially those in Southern Europe and those with 
badger populations (Ashbee et al., 2008; Craven 
2013; Eisenberg et al., 2013), suggesting that 
extending the documentation of further case reports 
of histoplasmosis in Europe would give a completely 
different local picture of Histoplasma epidemiology.
There are several reports of point-source outbreaks of 
acute pulmonary histoplasmosis among speleologists, 
so called »cave disease«, largely but not exclusively 
related to cave exploration in the tropics and sub-
tropics. The documented areas of cave disease in 
Europe are confined to underground spaces in Cyprus 
and to Topolnița Cave in Romania (Craven, 2013). The 
diagnosis of histoplasmosis is indicated initially by 
the history of simultaneous exposure to bat guano 
and subsequent simultaneous onset of symptoms, 
and can then be confirmed in the individual by the 
presence of radiographic abnormalities and by the 
results of a suite of mycological and/or non-culture 
based tests. For such a potentially vulnerable 
population, it is of great importance to collect 
information about the prevalence of Histoplasma in 
any particular underground system. The isolation of 
H. capsulatum from environmental samples is difficult.
The pathogen is typically retrieved as a cultivable
strain after inoculation of laboratory animals
(Richardson & Warnock, 2003). Direct identification
of the fungus from complex environmental samples
by use of molecular techniques is an alternative to the
time-consuming culturing methods (Frias De Leon
et al., 2012).
In this study we tested the usefulness of the 
commercial ALPHA Histoplasma Antigen EIA 
kit intended for human in vitro diagnostics of 
histoplasmosis (Cloud et al., 2007) as a rapid and cost-
effective alternative to culturing methods of inoculated 
laboratory animals for environmental samples. Since 
there have been no reports from Slovenia, a small 
Central European country, on either the presence 
of H. capsulatum in caves or of bats infected with 
histoplasmosis (McMurray & Greer, 1979), bat guano 
samples from five Slovenian bat-inhabited karst 
caves were screened for Histoplasma antigen and the 
results compared with those of molecular analyses. 
Additionally, we analysed risk factors for acquiring 
histoplasmosis, both in a group of 14 speleologists 
and in five travellers with imported pulmonary 
histoplasmosis who consulted the Infectious Disease 
Department at the Clinical Centre in Ljubljana 
between 2005 and 2016.
MATERIAL AND METHODS
Collection of bat guano and sample preparation
Five Slovenian bat-inhabited karst caves containing 
significant deposits of guano in a form of a heap, 
sampled in 2011-2012, were included in the study. 
Out of six samples, two samples of bat guano were 
obtained from Škocjan Caves (Škocjanske jame, E 
13.994° N 45.665°) and one sample from each of the 
following caves: Huda Luknja Cave (Huda luknja, 
E 15.1743° N 46.4145°); Predjama Cave (Predjama, 
E 14.1265° N 45.8156°); Spodnja Klevevška Cave 
(Spodnja klevevška jama, E 15.2334° N 45.9067°); and 
Turjeva Cave (Turjeva jama, E 13.5046° N 46.2435°). 
These guano heaps had already been screened for 
the fungus Pseudogymnoascus destructans (formerly 
known as Geomyces destructants), a bat pathogen, 
and for free-living amoebae during previous studies 
(Mulec et al., 2013, 2016). The authors did not 
interact directly with any bats during sample 
collection. Briefly, in caves, the guano was sampled 
aseptically from the upper layer of the guano heaps, 
from zero to five cm in depth, and stored at -20°C 
until analysed in a laboratory. The age of samples 
was estimated at the sites of guano collection. “Fresh” 
guano samples were characterized by intact rod-
shaped excrement, indicating the ongoing presence of 
roosting colonies of bats at the sites. A “recent” age 
attribution was given to those samples that included 
some relatively recent rod-shaped excrement over 
an older guano base. Samples were considered “old” 
when the guano showed no characteristics of fresh 
and/or recent rod-shaped excrement, and if no bat 
colony had been recorded above the guano heap in 
recent times, usually within a period of a few decades. 
Basic information on guano is summarized in Table 1. 
Sampling of guano was approved by the Slovenian 
Environment Agency, Ministry of the Environment 
and Spatial Planning, Republic of Slovenia (Nos. 
35602-63/2009-3, 35602-136/2010-3).
Antigen detection in guano
In the laboratory, 1 g of each guano sample was 
suspended in 10 ml of sterile RPMI 1640 – Hepes 
cell culture medium (Sigma, USA) and vortexed 
vigorously. These biomass suspensions (1:11 [w/v]) 
were centrifuged for 5 minutes at 4°C and 9200g. The 
supernatants were collected undiluted and further 
diluted 10-fold with sterile RPMI 1640 – Hepes, 
and stored at -20°C pending further analysis. The 
ALPHA Histoplasma Antigen EIA kit (Immy, USA), a 
commercially available enzyme immunoassay (EIA) 
for in vitro diagnostic use in human serum and urine 
samples was used to detect Histoplasma antigen in 
the guano supernatants. Results were expressed as 
EIA Units of Histoplasma antigen. Two commercial 
Histoplasma-antigen preparations needed for the 
determination of anti-Histoplasma-antibodies using 
the complement fixation method, i.e., Histoplasma 
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Cave Temperature (°C) Bats number Relative guano age / heap volume (l)
Huda Luknja Cave 9 2200 Recent (630)
Predjama Cave 12 1320 Recent (50)
Spodnja Klevevška Cave† 18 400 Fresh (30)
Škocjan Cave 12 5300 Fresh (400), Old (450)
Turjeva Cave 10 100 Old (800)
†Cave with a thermal spring
Table 1. List of bat guano collection sites (Mulec et al., 2013, 2016). 
Mycelia CF Antigen and Histoplasma Yeast CF Antigen 
(Immy, USA), were included in the test as additional 
positive controls.
DNA isolation and molecular analyses of bat guano
DNA isolated, using the NucleoSpin® Soil kit with 
SL2 lysis buffer (optimized protocol for guano samples 
by Macherey-Nagel, Germany), in a previous study 
(Mulec et al., 2013), has been used in the present 
analysis. Using the whole-cell DNA, nucleotide 
sequences of a highly conserved region of the fungal 
rRNA gene were amplified with two primer sets, i.e., 
ITS1-ITS4 and ITS4-ITS5 in a control polymerase 
chain reaction – PCR (http://www.biology.duke.edu/
fungi/mycolab/primers.htm). 
H. capsulatum-specific PCR assays using two sets 
of specific primers (H-anti3-H-anti4 and Msp2F-
Msp2R), the regions of H-antigen precursor and 
M-antigen genes (Guedes et al., 2003; de Muniz et 
al., 2010) were performed. PCR was carried out with 
serially diluted positive-control DNA to determine 
the analytical sensitivity of the test. Amplification 
products were analysed on 1% agarose gels, stained 
with SYBR Safe DNA gel stain (Invitrogen, USA) and 
electrophoresed at 140 V for 20 minutes.
Extraction, amplification, and sequencing  
of DNA from clinical samples
The serum specimens from four histoplasmosis 
patients, who did not belong to the group of examined 
speleologists, were available from the archival 
serum collection of the Institute of Microbiology 
and Immunology, Faculty of Medicine, University of 
Ljubljana, and used to extract DNA. Additionally, 
total DNA was extracted from paired specimens (urine 
and serum) from three speleologist volunteers who 
exhibited positive or equivocal Histoplasma antigen 
assay in urine. DNA templates were obtained by 
using the automatic commercial isolation kit MagNA 
Pure Compact Nucleic Acid Isolation Kit I (Roche 
Diagnostics, Mannheim, Germany) according to the 
manufacturer’s instructions. For the investigation 
of fungi-specific DNA in clinical samples, two sets 
of universal fungal primers were used as described 
above. 
For sequencing, the amplified PCR products 
of the proper size (≈ 620 bp) were purified using 
Exonuclease I (Exo I) and FastAP™ Thermo sensitive 
Alkaline Phosphatase (Thermo Scientific, Waltham, 
USA) according to the recommendations of Werle et 
al. (1994). DNA sequencing reactions were purified 
using a BigDye XTerminator® Purification Kit (Applied 
Biosystems®, USA) and sequencing was done in a 
3500 Genetic Analyser (Applied Biosystems®, USA). 
Finally, sequences were analysed using CLC Main 
Workbench 6.9.1 (CLC bio, Denmark). H. capsulatum-
specific PCR was performed as previously described.
Speleologists and analysis of the risk factors  
for acquiring histoplasmosis
A questionnaire, which was addressed specifically 
at speleologists who work and explore caves and 
come into direct and/or indirect contact with 
aerosols derived from bat guano, was composed, 
and distributed to 14 speleologist volunteers. 
These speleologists professionally work in caves, 
most of them being active researchers. They were 
advised to test for histoplasmosis by their employer 
and physician as they are frequently exposed to 
work in potentially biohazardous environments. 
The questionnaire comprised three parts: travel 
history to known endemic areas and visits to caves 
in those regions, information about speleological 
activities, and data on any accidents in the caves 
that might have led to infection with H. capsulatum 
(Appendix: Histoplasmosis Questionnaire). Each 
speleologist was examined by the same physician to 
assess health status, and screened for the presence 
of anti-histoplasmin antibodies (in serum) by 
immunodiffusion (ID) assay (Meridian, USA), and 
Histoplasma antigen (in serum and urine) by ALPHA 
Histoplasma Antigen EIA (Immy, USA) according to 
the manufacturer’s instructions. Urine samples were 
screened untreated and undiluted; however, serum 
samples were treated with pronase (Immy, USA) 
according to the manufacturer’s instructions. The 
antigen EIA was considered to be negative when the 
antigen concentration was less than 2 EIA Units, to 
be equivocal when it was between 2 and 3 EIA Units, 
and to be positive when the concentration was above 
3 EIA Units. 
All samples from speleologists were obtained as a 
part of a preventive health examination recommended 
by the employer which initially included a complete 
physical examination and laboratory tests. Since 
laboratory testing did not include screening for the 
presence of anti-histoplasmin antibodies, Histoplasma 
antigen or H. capsulatum-specific DNA, further 
laboratory tests had been requested by the responsible 
clinician. Informed consent for additional laboratory 
testing and analysing the data was obtained in 
writing from all those who completed Histoplasmosis 
questionnaire. All speleologists and samples were 
anonymized, no additional sample was taken for the 
purpose of the study and only speleologist’s age and 
gender were available to researchers.
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Patients and criteria for classification of cases
Five cases of imported pulmonary histoplasmosis, 
diagnosed at the Infectious Disease Department 
in the Clinical Centre at Ljubljana between 2005 
and 2016 were analysed retrospectively. A review 
of each patient’s medical record was provided by 
the treating physician to categorize individuals with 
histoplasmosis. The cases were classified following 
the European Confederation of Medical Mycology 
Working Group definitions (Ashbee et al., 2008). 
Histoplasmosis was considered probable when the 
individual had a travel history to a known endemic 
area, presented positive results to serological tests 
and where imaging of the lung revealed lesions 
consistent with histoplasmosis. Cases were classified 
as possible when the individual had a history of travel 
to a known endemic area and either showed a positive 
result to serological tests or if imaging of the lung 
revealed lesions consistent with histoplasmosis. Since 
laboratory testing initially included screening for the 
presence of anti-histoplasmin antibodies, additional 
retrospective Histoplasma antigen EIA was performed.
With regard to disease presentation, patients 
presenting with an acute primary infection after recent 
exposure to H. capsulatum risk factors were classified 
according to Wheat et al. (2016) as acute pulmonary; 
patients presenting with milder symptoms than those 
with an acute infection (symptoms are the same as but 
milder than those of acute histoplasmosis, with chest 
imaging showing focal or patchy opacities instead of 
diffuse bilateral) was classified as subacute pulmonary 
histoplasmosis. A patient who was asymptomatic, 
developed subclinical, self-limited, disease. 
The serum specimens for additional Histoplasma 
antigen EIA testing from four histoplasmosis patients 
were available from the archival serum collection of 
the Institute of Microbiology and Immunology, Faculty 
of Medicine, University of Ljubljana. We followed the 
principles of the Helsinki Declaration, the Oviedo 
Convention on Human Rights and Biomedicine, 
and the Slovene Code of Medical Deontology. All 
samples were anonymized and only patient’s age, 
gender, geographical destination of travelling, anti-
histoplasmin antibodies result, and therapy were 
available to researchers.
RESULTS
Histoplasma in bat guano
Fungal broad range PCR on total DNA isolated from 
guano samples confirmed the presence of fungal DNA 
in all samples. However, H. capsulatum-specific PCR 
assays using H-antigen and M-antigen primers that 
displayed the analytical sensitivity of 26.6 pg/µl were 
negative (Fig. 1). In a direct approach to determine 
the specific fungus sequence, no sequence related to 
H. capsulatum was retrieved in any of the bat guano 
samples.
All six guano samples from Slovenian caves were 
positive for Histoplasma antigen in both undiluted and 
10-fold diluted supernatants, determined by EIA (Fig. 1). 
The sample of old guano from Turjeva Cave had the 
highest antigen content. Because of the limited number 
of samples, the effect of guano age on Histoplasma 
antigen remains elusive. Because concentrations of 
Histoplasma antigen were substantially higher in all 
10-fold diluted supernatants than in the undiluted 
ones, unspecific, false positive antigen results in 
guano samples were suspected. Both commercial 
antigen preparations (mycelial and yeast phase 
Histoplasma antigen), tested positive, showing 232.3 
EIA Units and 145.4 EIA Units respectively.
Fig. 1. Histoplasma Antigen EIA content in bat guano samples was not supported by the molecular analyses. A) Two 
universal fungal primer pairs, ITS1-ITS4 and ITS4-ITS5, and two H. capsulatum-specific primer pairs, H-anti3-H-anti4 
and Msp2F-Msp2R, were used for the analysis of genomic DNA; B) Histoplasma antigen was measured by the ALPHA 
Histoplasma Antigen EIA in undiluted (1:11 [w/v]) and in 10-fold diluted (1:110 [w/v]) guano supernatants.
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Taken together, Histoplasma Antigen EIA results 
were not supported by the molecular analyses.
Epidemiological characteristics and diagnosis  
of histoplasmosis in speleologists
A total of 14 speleologists were studied (seven 
females, seven males). Their mean age was 39.7 years 
(the youngest was 27 and the oldest 58 years old). Two 
speleologists reported nonspecific health problems 
at the time of the visit at our clinic. Otherwise they 
were all healthy individuals, without any known 
immunosuppression and with unremarkable medical 
histories. 
Most of the subjects had been active speleologists 
for a number of years, ranging from 4 to 43 years, 
with the mean of 17.5 years. Visits to caves once 
a week were reported in five cases (35.7%), once a 
month in seven cases (50%) and several times a year 
for one (7.1%) person. One person didn’t specify the 
frequency. The speleologists visited caves in different 
regions of the world. North-American caves were 
visited by ten (71.4%) of the speleologists, Central-
American by six (42.9%), South-American by four 
(28.6%), African by three (21.4%), Australian by five 
(35.7%), and Southeast-Asian and Indian caves by 
ten speleologists (71.4%). Five speleologists (35.7%) 
reported visiting only touristic caves, 8 (57.1%) also 
visited other wild caves, and one person (7.1%) didn’t 
provide an answer. None of the persons complained 
about health problems when returning from caves. 
Protective measures were employed by five persons 
(35.7%), all measures except for use of a protective face 
mask were reported by three speleologists (21.4%), 
whereas six people (42.9%) used no protection.
None of the 14 speleologists reported a bite by a bat. 
One had an accident in the cave, but with no serious 
consequence. Known contact with bats or guano were 
reported by nine (64.3%) of the subjects.
Results of the medical check-up were unremarkable 
in all 14 speleologists. In spite of having risk factors 
for acquiring infection with H. capsulatum, all 
speleologists tested negative by immunodiffusion and 
Histoplasma antigen EIA in serum (Table 2). For all 
but three, Histoplasma antigen EIA results in urine 
were negative. One person showed an equivocal 
antigen EIA test result in urine (2.0 EIA Units) and 
two results were low positive (3.9 and 3.2 EIA Units). 
PCR was performed on serum and urine samples from 
these three speleologists and results for H. capsulatum 
were negative in all cases (Table 2). The speleologist 
positive for the Histoplasma Ag (3.9 EIA Units) 
reported in his questionnaire that he visited some of 
the endemic areas (Northern America, Mexico, India 
and Indonesia) and he gets occasionally in contact 
with guano and bats. Broad range PCR revealed the 
presence of Cladosporium sp. in his urine. The second 
speleologist (3.2 EIA Units) reported visits in North 
America, India and Malesia, occasional contacts with 
bat guano, and she had Malassezia restricta in her 
urine and serum.
Table 2. Demographic characteristics of speleologists and results of diagnostic tests for histoplasmosis performed.
Speleologist Sex Sample PCR result ID result Histoplasma Ag result (EIA Units)
1 Male
Serum ND Negative Negative
Urine ND Negative
2 Male
Serum Negative Negative Negative
Urine Negative Positive (3.89)
3 Female
Serum Negative Negative Negative
Urine Negative Positive (3.19)
4 Female
Serum ND Negative Negative
Urine ND Negative
5 Female
Serum ND Negative Negative
Urine ND Negative
6 Male
Serum Negative Negative Negative
Urine Negative Equivocal (2.02)
7 Female
Serum ND Negative Negative
Urine ND Negative
8 Male
Serum ND Negative Negative
Urine ND Negative
9 Male
Serum ND Negative Negative
Urine ND Negative
10 Male
Serum ND Negative Negative
Urine ND Negative
11 Female
Serum ND Negative Negative
Urine ND Negative
12 Male
Serum ND Negative Negative
Urine ND Negative
13 Female
Serum ND Negative Negative
Urine ND Negative
14 Female
Serum ND Negative Negative
Urine ND Negative
PCR, polymerase chain reaction; ID, immunodiffusion test; EIA, enzyme immunoassay; Ag, antigen; ND, not done
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Epidemiological characteristics and diagnosis  
of histoplasmosis in travellers
During the last ten years five cases of histoplasmosis 
among travellers were diagnosed at the Infectious 
Disease Department of the Clinical Centre Ljubljana, 
Slovenia (Table 3). At the time of presentation, based 
on epidemiological data, clinical symptoms, and X-ray 
imaging, four patients had a highly-likely suspicion 
for pulmonary histoplasmosis (patients 1, 2, 4, 
and 5). The most common symptoms were cough, 
headache, myalgia, fever, and chest pain. One person 
was asymptomatic (patient 3) and was traveling with 
the patient who presented with acute pulmonary 
histoplasmosis (patient 2). They were all males, 
with mean age of 37.2 years without any underlying 
diseases, and with no known immune deficiency. 
The epidemiological background of patients included 
travel to Histoplasma-endemic regions. One patient 
had spent much time doing outdoor activities in 
National Parks throughout the Mississippi Valley, 
USA, two patients had collected bat guano for soil 
fertilizer in non-touristic caves in Jamaica, and two 
patients had visited rural areas, but not caves with bat 
guano in Venezuela and Ecuador. None of them was 
a speleologist. They were not aware of the potential 
presence of H. capsulatum in the region, and no one 
adopted any personal protection measures against 
the pathogen.
On medical examination, the lungs were normal 
on auscultation in four patients; one patient was 
displaying signs of pathological compromise of the 
lungs (patient 1). The rest of examination was not 
remarkable. Pathological chest radiographs for four 
patients were consistent with histoplasmosis (patients 
1, 2, 4, and 5). Prompted by the pathology seen on 
the chest radiographs, computed tomography (CT) 
scans of the chest were performed. Pathology highly 
Patient Age Sex Travelled to Sample PCR result
ID 
result
Histoplasma 
Ag result 
(EIA Units)
Classification 
of 
histoplasmosis
Clinical 
category Therapy
1 51 Male
USA
(Mississippi 
Valley)
Serum Negative
Positive
(M 
band)
Negative Probable
Severe acute 
pulmonary 
histoplasmosis
Itraconazole
200 mg TID for 
3 days
then 200 mg 
BID for a total of 
12 weeks
2 32 Male Jamaica(wild caves) Serum Negative
Positive
(M 
band)
Positive 
(3.66) Probable
Acute 
pulmonary 
histoplasmosis
Itraconazole
200 mg TID for 
3 days
then 200 mg 
BID for a total of 
6 weeks
3 27 Male Jamaica(wild caves) Serum Negative
Positive
(M 
band)
Equivocal 
(2.51) Not classified
Subclinical 
histoplasmosis No
4 39 Male
Venezuela
(outdoor 
activities)
Serum Negative
Positive
(M 
band)
Positive 
(3.91) Probable
Subacute 
pulmonary 
histoplasmosis
No
5 35 Male
Ecuador
(outdoor 
activities)
Serum ND Negative ND Possible
Acute 
pulmonary 
histoplasmosis
Itraconazole
200 mg TID for 
3 days
then 200 mg 
BID for a total of 
8 weeks
PCR, polymerase chain reaction; ID, immunodiffusion test; EIA, enzyme immunoassay; Ag, antigen; ND, not done; TID, three times daily; 
BID, twice daily.
Table 3. Epidemiological characteristics, results of diagnostic tests performed, classification of cases based on the European Confederation of 
Medical Mycology Working Group criteria, clinical category and therapy of Slovenian travellers with histoplasmosis.
indicative of pulmonary histoplasmosis was confirmed 
in all four patients.
Out of four patients with respiratory symptoms and 
indicative results of pathological chest imaging, three 
patients showed positive immunodiffusion results; 
one patient was seronegative. A patient who was 
asymptomatic tested positive by immunodiffusion. 
Out of four seropositive patients, two had the positive 
antigen EIA test in serum, one was equivocal, and one 
tested negative. Tests for H. capsulatum-specific PCR 
were performed on serum samples from four seropositive 
patients and results were negative in all cases.
In addition, three patients met the criteria for 
probable histoplasmosis and one patient for possible 
histoplasmosis. A patient who was asymptomatic 
and seropositive, had subclinical, self-limited 
histoplasmosis. In all, three patients presented with 
acute pulmonary histoplasmosis (patients 1, 2, and 
5), of whom two patients were classified as probable 
and one patient as possible histoplasmosis; therapy 
with itraconazole was initiated. All three patients 
received an initial dose of 200 mg of itraconazole three 
times daily for three days. Thereafter, itraconazole 
was administered with the dose of 200 mg twice 
daily for a total of 12 weeks in patient 1, 6 weeks in 
patient 2 and 8 weeks in patient 5. All three patients 
responded well to therapy and the pathology seen on 
the chest radiographs was completely abrogated after 
several months. The patient with subacute pulmonary 
histoplasmosis and the asymptomatic one were not 
treated.
DISCUSSION
A small but significant number of autochthonous 
cases of histoplasmosis reported in European 
countries, especially in neighbouring Italy (Manfredi 
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et al., 1994; Farina et al., 2000, 2005; Calza et al., 
2003; Ashbee et al., 2008), leads us to consider 
whether H. capsulatum might not be confined to 
only a limited region but might actually be an 
autochthonous inhabitant of Central Europe, 
including Slovenia. In the study, the commercial 
ALPHA Histoplasma Antigen EIA kit designed for 
human in vitro diagnostics of histoplasmosis was 
applied for the first time to capture H. capsulatum 
antigen from bat guano heaps, not mixed with the 
surrounding cave material. The 10-fold diluted guano 
supernatants revealed a substantially higher antigen 
content than did undiluted supernatants (Fig. 1), 
implying that conditions in guano might have been 
the reason for discordant results and probably for 
non-specific reactions. For example, reactive antigen 
EIA might be linked to the cross-reactivity of rabbit 
anti-Histoplasma IgG antibodies used in the test with 
polysaccharide antigens of diverse and abundant 
guano-associated microorganisms rather than H. 
capsulatum (Chroňaková et al., 2009; Nieves-Rivera et 
al., 2009). Indeed, our previous study demonstrated 
that the sampled guanos are rich sources of cultivable 
fungi and bacteria (Mulec et al., 2013), but species 
identification was not carried out. Fungi associated 
with bat guano are diverse (Nováková, 2009). Besides 
being a source of nutrients and microbiota, guano as 
a complex environmental sample can also vary in pH, 
ranging from acidic to alkaline (Mulec et al., 2013) 
and is known to contain high levels of heavy metals 
(Walker et al., 2007; Krištůfek et al., 2010), which all 
together could facilitate the non-specific reactions in 
the Histoplasma antigen EIA.
The PCRs with the primers specific for H. capsulatum 
var. capsulatum (Guedes et al., 2003; de Muniz et 
al., 2010) were performed on total DNA isolated 
from the guano samples and nucleotide sequences 
of a highly conserved region of the fungal rRNA gene 
were analysed. Although the guano samples tested 
Histoplasma-antigen positive, no H. capsulatum-
specific PCR products were detected and no sequences 
related to H. capsulatum were retrieved from any of the 
bat guano samples (Fig. 1). The results indicated that 
the commercial ALPHA Histoplasma Antigen EIA kit 
is probably not applicable for complex environmental 
samples such as bat excrement. 
On the other hand, the negative results of the 
specific PCRs can point out that concentrations of 
H. capsulatum DNA in the samples were below the 
detection limit. It might also be that bat species 
identified in Slovenian caves are not the natural hosts 
of the fungus, and consequently the fungus is not 
yet present in guano. Several bat species have been 
identified in caves in Slovenia; however, the main 
origin of screened guano was from the bat Miniopterus 
schreibersii (Mulec et al., 2016), which is not yet 
reported to host H. capsulatum (Stančič-Pavlinčič and 
Grom 2005). Although the presence of reactive antigen 
EIA was not supported by the molecular analyses and 
therefore H. capsulatum was probably not present 
in bat guano, the possibility of transmission of the 
fungus by a different species of bat in Slovenia cannot 
be excluded. Further work is needed to screen guano 
from other caves for the presence of H. capsulatum or 
the association of histoplasmosis in bats.
The increasing number of people travelling to 
Histoplasma-endemic areas is responsible of the 
growing number of reports of single or, more 
frequently, clusters of acute histoplasmosis cases. 
The continued reports of cave-associated outbreaks 
suggest that current caving practices continue to 
place cavers at risk from the infection, as a particularly 
vulnerable population (Senechal et al., 2012; Bahr 
et al., 2015; Benedict & Mody 2016). By analysing 
cases of imported pulmonary histoplasmosis in 
Slovenia retrospectively, our findings, reported 
here for the first time, suggest that visiting caves in 
Histoplasma-endemic areas and coming into contact 
with bat guano without the use of personal protective 
equipment were the major risk factors for acquiring the 
infection in the travellers group. Although several risk 
factors for acquiring histoplasmosis were indicated 
for the speleologists group, e.g., visiting confined 
underground spaces in endemic areas, contact with 
the bats or their guano and inadequate employment 
of protective measures, none of them showed clinical 
signs and/or symptoms of histoplasmosis at the 
time of medical examination. We highlight a general 
lack of awareness of this disease among professional 
speleologists and other cave explorers, who should use 
personal protective equipment to prevent infection. 
For example, two of the professional speleologists 
from the studied group (speleologists no. 4 and no. 
6 in Table 2) did not acquire histoplasmosis during 
the international cave exploration in Viñales, (Cuba), 
whereas another speleologist from the international 
caving group who was not wearing a protection mask, 
and did not participate in the current study, got 
histoplasmosis. In the speleologists group, personal 
protective equipment and/or measures were used 
only by five persons (35.7%); nine persons (64.3%) 
did not use protective face masks and six persons 
(42.9%) did not use any protection. Travelers and not 
only speleologists who visit endemic areas should be 
better informed on risk factors for histoplasmosis and 
its prevention. The contribution of histoplasmosis 
to travellers’ and cavers’ morbidity is probably 
underestimated in non-endemic areas (Buitrago et 
al., 2011; Senechal et al., 2012). Even if it is usually a 
self-limited illness in immunocompetent individuals, 
European clinicians should consider it routinely 
when examining any person with febrile respiratory 
syndrome who has recently been involved in outdoor 
activities or visited caves, not only in endemic areas 
but also in Europe.
Serologic ID assay for the presence of M and H 
precipitin bands plays an important role in the 
diagnosis of acute pulmonary histoplasmosis 
(Kauffman, 2007); however, false-negative results 
may occur for patients with recent infection. Out of 
five Slovenian travellers with histoplasmosis, four had 
solely an M band and one patient was seronegative. 
It is noteworthy that the seropositive traveller with 
severe acute pulmonary histoplasmosis tested as 
Histoplasma-antigen negative in serum; however, 
urine was unfortunately not available for reaching a 
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diagnosis. Published reports note that antigenuria is 
far more common than antigenemia, not only in AIDS 
patients with disseminated histoplasmosis, but also in 
patients with acute pulmonary histoplasmosis (Wheat 
& Kauffman, 2003). The negative antigen result in the 
Alpha Histoplasma antigen EIA might be due to the lack 
of polyclonal antibodies to detect a specific antigenic 
epitope, but, alternatively, myriad antigenic epitopes 
on the target molecules that are present in biological 
samples may vary over the course of the disease 
(Cloud et al., 2010). PCR in serum was negative in all 
four travellers, probably due to the limited amount 
of DNA circulating in immunocompetent patients 
(Buitrago et al., 2011). In contrast with sera or blood 
samples, respiratory samples that would undoubtedly 
confirm the presence of pathogen (Kauffman, 2007; 
Wheat et al., 2016) have not been available and even 
contra-indicated for the patient with severe disease. 
The final aspect deserving discussion is the 
inconsistency between Histoplasma antigen EIA 
in urine and other laboratory and clinical findings 
recorded in two speleologists (Table 2). In spite 
of having risk factors for acquiring infection with 
H. capsulatum, medical check-up results were 
unremarkable for all 14 speleologists. Additionally, 
none of them complained about health problems when 
returning from caves or developed histoplasmosis in 
the year following initial testing. Since all speleologists 
tested negative by immunodiffusion and Histoplasma 
antigen EIA in serum (Table 2), an additional medical 
check-up was not indicated and a phenomenon 
of seroconversion was hardly to expect. They were 
either out of Histoplasma-endemic regions or with 
no records of visiting caves at least 8 weeks before 
medical examination, therefore we did not repeat 
the serological tests. The above-mentioned two 
speleologists with discordant findings had weakly 
positive urine antigen test results (Table 2), no signs 
of either histoplasmosis or other endemic mycoses, 
which have been described as causing false-positive 
reactions for Histoplasma antigen in urine (Kauffman, 
2007), and none of them developed histoplasmosis 
in the year following initial testing. However, DNA 
sequences related to Cladosporium sp. and Malassezia 
restricta were retrieved from urine samples, fungi that 
are not yet known to cause false-positive reactions. 
Since the specificity for healthy subjects and 
individuals without histoplasmosis was reported to 
be from 84-92% with the Immy EIA (LeMonte et al., 
2007; Cloud, 2010) and because diagnosis should 
never be based on a urine Histoplasma antigen test 
alone (Kauffman 2007), the diagnosis of an active 
infection has not been established.
In conclusion, we have shown that the reactive Immy 
Histoplasma antigen EIA for complex environmental 
samples such as bat excrement was not supported 
by the results of molecular analyses. We highlight 
the widespread lack of awareness of histoplasmosis 
among persons exploring caves, who should use 
personal protective equipment to help prevent 
infection, particularly during exploration in endemic 
areas. Although five imported cases of pulmonary 
histoplasmosis were diagnosed in Slovenia during the 
last ten years, we infer from our sequencing results 
from bat guano and the fact that, to date, there have 
been no reports of autochthonous histoplasmosis 
among tourists, speleologists or bat researchers 
visiting Slovenian caves, that H. capsulatum is 
probably not present in the caves of Slovenia. On the 
other hand, histoplasmosis should be considered in a 
differential diagnosis for a febrile respiratory disease 
outbreak in returning travellers with a history of 
geographical exposure.
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